Jeremiah Bivins, MD
Allergy & Immunology · Knoxville, TNNPI 1831355833
Payments from drug & device makers
Across 517 payments — averaging $20.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- GSK$1K
- Regeneron Healthcare Solutions, Inc.$1K
- Sanofi$838
- Pfizer$724
- CSL Behring$537
- plus $4K from 26 others
What the payments were for
- Food & beverage$10,479100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 136 | $2,543 |
| GSK | 67 | $1,219 |
| Regeneron Healthcare Solutions, Inc. | 50 | $1,088 |
| Sanofi | 30 | $838 |
| Pfizer | 45 | $724 |
| CSL Behring | 24 | $537 |
| Biocryst US Sales Co., LLC | 24 | $489 |
| Amgen(2 entities) | 19 | $446 |
| Genentech USA, Inc. | 22 | $412 |
| Kaleo, Inc. | 20 | $344 |
| Novartis | 13 | $278 |
| Octapharma USA, Inc. | 2 | $271 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $255 |
| Grifols USA, LLC | 10 | $202 |
| Teva Pharmaceuticals USA, Inc. | 8 | $117 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $90 |
| Shire North American Group Inc | 4 | $69 |
| Boehringer Ingelheim | 4 | $67 |
| Incyte Corporation | 3 | $61 |
| Organon | 2 | $51 |
| Pharming Healthcare, Inc. | 2 | $46 |
| Dermavant Sciences, Inc. | 2 | $44 |
| LEO Pharma Inc. | 2 | $44 |
| Optinose US, Inc. | 2 | $42 |
| Hikma Pharmaceuticals USA | 2 | $38 |
| USWM, LLC | 2 | $37 |
| Boston Scientific | 2 | $36 |
| Lilly USA, LLC | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| Galderma Laboratories, L.p. | 1 | $21 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| Circassia Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CUTAQUIG$194
How this compares
$10,487 in reported general payments places this provider in the 70th percentile of 79 allergy & immunology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrladeyoBerotralstat Hydrochloride | 13 | $574,992 |
| FasenraBenralizumab | 44 | $239,961 |
| Dupixent SyringeDupilumab | 59 | $220,172 |
| XolairOmalizumab | 57 | $153,539 |
| TezspireTezepelumab-Ekko | 34 | $134,382 |
| Fasenra PenBenralizumab | 11 | $65,237 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 58 | $53,493 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 66 | $47,657 |
| Breo ElliptaFluticasone/Vilanterol | 51 | $22,480 |
| SymbicortBudesonide/Formoterol Fumarate | 57 | $17,353 |
| Arnuity ElliptaFluticasone Furoate | 38 | $10,349 |
| Epinephrine | 44 | $9,422 |
| Advair HfaFluticasone Propion/Salmeterol | 16 | $7,357 |
| Ipratropium Bromide | 199 | $6,129 |
| DuleraMometasone/Formoterol | 14 | $4,691 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Biocryst US Sales Co., LLCOrladeyo | $489 | $574,99213 claims |
| AstraZenecaFasenra, Tezspire, Breztri Aerosphere, Symbicort | $2,543 | $445,189193 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $1,219 | $80,486155 claims |
| Hikma Pharmaceuticals USAEpinephrine | $38 | $9,42244 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $117 | $4,33912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 79 allergy & immunology providers in Tennessee.
Other allergy & immunology in Knoxville
- Nicholas KolinskyKnoxville$472K
- Nicholas ClineKnoxville$29K
- Joseph EllenburgKnoxville$10K
- Jeffrey SchlactusKnoxville$9K
- Sangeetha KodothKnoxville$8K
- Michael SpringerKnoxville$7K
- Laura GreenKnoxville$7K
- Andrew SingerKnoxville$6K
- Donald EllenburgKnoxville$6K
- Jane ConleyKnoxville$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.